{"store":{"baseInfo":{"podcastTitle":"The shanghaichemicals's Podcast","slug":"shanghaichemicals","podcastDescription":"New podcast weblog","podcastLogo":"https://pbcdn1.podbean.com/img/podbean-logo/podbean_74.jpg","podcastShareLogo":null,"podcastUrl":"https://shanghaichemicals.podbean.com","podcastCanSearched":false,"feedUrl":"https://feed.podbean.com/shanghaichemicals/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pw/pbblog-9wiv9-9c60dd","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":54,"gmtAdjustment":"GMT+05:00","useDaylightTime":1,"value":5,"text":"(GMT+05:00) Yekaterinburg","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"Asia/Yekaterinburg"},"podcastDownloads":null,"totalEpisodes":3,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"shanghaichemicals","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-9wiv9-9c60dd-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Podbean App","link":"https://podbeanapp.page.link/?link=https%3A%2F%2Fshanghaichemicals.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog10248413%26podcastIdTag%3D9wiv9&dfl=https%3A%2F%2Fshanghaichemicals.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"simple-list"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/pJvY1rCEqubX","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-9jbO05f07ul1","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright {year} All Rights Reserved"},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":["https://www.googletagmanager.com/gtag/js?id=G-TP93LLY3WQ","\n window.dataLayer = window.dataLayer || [];\n function gtag(){dataLayer.push(arguments);}\n gtag('js', new Date());\n\n gtag('config', 'G-TP93LLY3WQ',{'allow_enhanced_conversions':true});\n"],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":false,"sectionMaxCount":10,"enableEditorLink":false,"enableEditCookiesNotice":false,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://shanghaichemicals.podbean.com","apiCommonParams":{"t":"682d359b","clientSignature":"fc7fea7e18b56602d3c280c28000116b","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb15934482-i84f3","episode":{"id":"pb15934482","idTag":"i84f3","title":"1CP-LSD – A New Addition to Lysergamide-Based Designer Drugs Group","logo":"https://pbcdn1.podbean.com/img/podbean-logo/podbean_74.jpg","shareLogo":null,"largeLogo":"https://pbcdn1.podbean.com/img/podbean-logo/podbean_74.jpg","previewContent":null,"content":"

Ficher Chem Co. Ltd. is a certified 1CP-LSD Manufacturer and Shanghai Chemicals is a certified online supplier that supplies this chemical for legal research and laboratory. //shanghaichemicals.co/1cp-lsd-a-new-addition-to-lysergamide-based-designer-drugs-group/

","publishTimestamp":1606194548,"duration":228,"mediaUrl":"https://mcdn.podbean.com/mf/web/37t2an/1CP-LSD_A_New_Addition_to_Lysergamide-Based_Designer_Drugs_Group9ozbk.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-i84f3-f32412","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-i84f3-f32412","transcriptUrl":null,"permalink":"/e/1cp-lsd-%e2%80%93-a-new-addition-to-lysergamide-based-designer-drugs-group/","downloadLink":"https://www.podbean.com/media/share/pb-i84f3-f32412","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":1,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-i84f3-f32412","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb15934482","idTag":"i84f3","title":"1CP-LSD – A New Addition to Lysergamide-Based Designer Drugs Group","logo":"https://pbcdn1.podbean.com/img/podbean-logo/podbean_74.jpg","shareLogo":null,"largeLogo":"https://pbcdn1.podbean.com/img/podbean-logo/podbean_74.jpg","previewContent":null,"content":"

1CP-LSD – A New Addition to Lysergamide-Based Designer Drugs Group

Comments (0)